In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Izabella Dudek-Urbanowicz comments the new UPRP project in daily Puls Biznesu

Izabella Dudek-Urbanowicz, Managing Director of Patpol, comments in the latest article in daily Puls Biznesu by Czytaj dalej

Information Claim in Industrial Property Law. Part 2

The previous article presented an informational claim, including its genesis and the previous regulation in Czytaj dalej

Validation, a short guide part I – What is validation?

The word "validation" by itself has a few meanings. The Dictionary of the Polish Language Czytaj dalej